Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9147483 | 0.82 | FFAR3 (0.41) | ALDH1A1FFAR3MEN1CYP1A2THRB | |
| SCHEMBL232174 | 0.75 | — | — | |
| SCHEMBL3053815 | 0.74 | TSHR (0.40) | ALDH1A1FFAR3MEN1CYP1A2THRB | |
| SCHEMBL471905 | 0.74 | FFAR3 (0.35) | ALDH1A1FFAR3MEN1CYP1A2THRB | |
| SCHEMBL276477 | 0.74 | TSHR (0.40) | ALDH1A1FFAR3MEN1CYP1A2THRB | |
| SCHEMBL5850679 | 0.74 | FFAR3 (0.35) | ALDH1A1FFAR3MEN1CYP1A2THRB | |
| SCHEMBL21269356 | 0.72 | TSHR (0.38) | ALDH1A1FFAR3MEN1CYP1A2THRB | |
| SCHEMBL5003423 | 0.72 | TSHR (0.38) | ALDH1A1FFAR3MEN1CYP1A2THRB | |
| SCHEMBL21269186 | 0.72 | TSHR (0.38) | ALDH1A1FFAR3MEN1CYP1A2THRB | |
| SCHEMBL21269649 | 0.72 | TSHR (0.38) | ALDH1A1FFAR3MEN1CYP1A2THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11492655-B2 | Method of detecting a nucleic acid | TORAY INDUSTRIES, INC. (JP) | 2022-11-08 | — | — | US | disclosed |
| CN-114181223-A | Cephalotaxine derivative and preparation method and application thereof | 广州艾格生物科技有限公司 | 2022-03-15 | — | — | CN | disclosed |
| EP-3546590-A1 | NUCLEIC ACID DETECTION METHOD | Toray Industries, Inc. (JP) | 2019-10-02 | — | — | EP | disclosed |
| US-20190276876-A1 | METHOD OF DETECTING A NUCLEIC ACID | TORAY INDUSTRIES, INC. (JP) | 2019-09-12 | — | — | US | disclosed |
| WO-2019142480-A1 | TEMPERATURE DETECTION INK, TEMPERATURE DETECTION INK INITIALIZATION METHOD, TEMPERATURE INDICATOR, AND ARTICLE MANAGEMENT SYSTEM | 株式会社日立製作所 | 2019-07-25 | — | — | WO | disclosed |
| WO-2019142485-A1 | TEMPERATURE DETECTION LABEL AND ARTICLE MANAGEMENT DEVICE USING SAME | 株式会社日立製作所 | 2019-07-25 | — | — | WO | disclosed |
| EP-2480666-B1 | COMPOSITIONS, METHODS, AND KITS FOR ISOLATING AND ANALYZING NUCLEIC ACIDS USING AN ANION EXCHANGE MATERIAL | QIAGEN GAITHERSBURG INC (US) | 2017-03-08 | — | — | EP | disclosed |
| US-20160375143-A1 | MIKTO-ARM BRANCHED POLYMERS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2016-12-29 | — | — | US | disclosed |
| US-9238809-B2 | Compositions, methods, and kits for isolating and analyzing nucleic acids using an anion exchange material | QIAGEN GAITHERSBURG, INC. (US) | 2016-01-19 | — | — | US | disclosed |
| EP-2480666-A1 | COMPOSITIONS, METHODS, AND KITS FOR ISOLATING AND ANALYZING NUCLEIC ACIDS USING AN ANION EXCHANGE MATERIAL | QIAGEN Gaithersburg, Inc. (US) | 2012-08-01 | — | — | EP | disclosed |
| US-5391818-A | Tricarboxylic acid-functional monomers and polymers prepared from same | THE SHERWIN-WILLIAMS COMPANY (US) | 1995-02-21 | — | — | US | disclosed |
| US-5349080-A | Ester-functional monomers and polymers prepared from same | THE SHERWIN-WILLIAMS COMPANY (US) | 1994-09-20 | — | — | US | disclosed |
| US-5328910-A | Bradycardial agents | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1994-07-12 | — | — | US | disclosed |
| US-5225431-A | Treatment of migraine | BURROUGHS WELLCOME CO. (US) | 1993-07-06 | — | — | US | disclosed |
| EP-0313397-B1 | THERAPEUTIC HETEROCYCLIC COMPOUNDS | THE WELLCOME FOUNDATION LIMITED (GB) | 1993-06-02 | — | — | EP | disclosed |
| EP-0231081-B1 | HYDROXAMIC ACIDS | ICI AMERICAS INC. (US) | 1993-03-17 | — | — | EP | disclosed |
| EP-0482804-A1 | Pyrrolo[2,3-d]pyrimidines with cardiovascular activity, process for their preparation and pharmaceutical compositions containing them | ZENECA LIMITED (GB) | 1992-04-29 | — | — | EP | disclosed |
| EP-0313397-A1 | Therapeutic heterocyclic compounds | THE WELLCOME FOUNDATION LIMITED (GB) | 1989-04-26 | — | — | EP | disclosed |
| US-4771038-A | Hydroxamic acids | ICI AMERICAS INC. (US) | 1988-09-13 | — | — | US | disclosed |
| EP-0231081-A2 | Hydroxamic acids | ICI AMERICAS INC. (US) | 1987-08-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160375143-A1 | MIKTO-ARM BRANCHED POLYMERS | MACO1, PCNA, IPO7 | ALDH1A1 4643/4885FFAR3 2749/4885MEN1 874/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.